Related by context. All words. (Click for frequent words.) 74 preserved ejection fraction 71 systolic dysfunction 70 diastolic dysfunction 68 left ventricular systolic 67 left ventricular dysfunction 67 systolic hypertension 66 aortic valve stenosis 66 acutely decompensated heart 66 β blockers 65 macroalbuminuria 65 left ventricular hypertrophy 65 NYHA Class II 65 antiarrhythmic drug 64 ejection fractions 64 LV dysfunction 64 paroxysmal AF 64 acute decompensated heart 64 microvascular disease 64 preserved systolic 64 ejection fraction 63 hyperkalemia 63 diastolic function 63 hemoglobin A1c levels 63 mixed hyperlipidemia 63 paroxysmal supraventricular tachycardia 63 coronary artery disease 63 ischemic cardiomyopathy 63 aortic regurgitation 63 nonischemic 63 revascularization procedures 63 isolated systolic hypertension 62 tolvaptan 62 atrial fibrillation 62 NYHA class 62 angina pectoris 62 renal dysfunction 62 morphometric vertebral fractures 62 biventricular pacing 62 resynchronization therapy 62 glycated hemoglobin levels 62 hypertensives 62 left ventricular diastolic 62 cardiac resynchronization 62 detrusor overactivity 62 diabetes mellitus DM 62 candesartan 62 macrovascular disease 62 bezafibrate 62 myocardial ischemia 62 stable angina 61 angiotensin converting enzyme inhibitors 61 aldosterone antagonists 61 onset atrial fibrillation 61 ventricular remodeling 61 decompensated heart failure 61 intermittent claudication 61 dobutamine 61 NATRECOR ® 61 metformin monotherapy 61 left ventricular ejection 61 orthostatic hypotension 61 alteplase 61 dysfunction LVSD 61 intravesical therapy 61 IV tPA 61 subclinical hypothyroidism 61 either acutely decompensated 61 arterial thrombosis 61 NYHA functional class 61 lipid lowering therapy 61 reflux symptoms 61 cardiogenic shock 61 artery blockages 61 CTEPH 61 Nesiritide 61 hypercholesterolemia 61 antithrombotic therapy 61 beta blocker therapy 61 thiazide diuretic 61 CIMZIA ™ 61 myocardial infarction 61 chronic thromboembolic pulmonary 61 colorectal liver metastases 61 peginterferon 61 reoperations 61 renal impairment 60 SERCA2a 60 BH4 60 systolic 60 paricalcitol 60 postoperative AF 60 myocardial infarctions 60 riociguat 60 milrinone 60 occlusive disease 60 angiotensin receptor blockers 60 arterial thromboembolic events 60 benazepril 60 primary aldosteronism 60 aortic stenosis 60 anticoagulant warfarin 60 percutaneous transluminal coronary angioplasty 60 multivessel disease 60 acutely decompensated congestive heart 60 HIV HCV coinfected 60 ATACAND 60 ACE Inhibitor 60 pericardial effusion 60 overactive bladder symptoms 60 cardiac resynchronisation therapy 60 thrombolytic therapy 60 Candesartan 60 resistant hypertension 60 nondiabetic patients 60 lupus nephritis 60 rolofylline 60 postoperative atrial fibrillation 60 acute myocardial infarction AMI 60 eplerenone 60 thrombotic events 60 cardiac dysfunction 60 ACE inhibitors 60 hemodialysis patients 60 levosimendan 60 diabetic kidney 60 aldosterone antagonist 60 antihypertensive therapy 60 antihypertensive medications 60 perioperative complications 60 valvular disease 60 subclinical hyperthyroidism 60 nonalcoholic steatohepatitis NASH 60 reflux disease 60 BENICAR HCT 60 colorectal adenoma 59 angina chest 59 serum triglyceride levels 59 LVEF 59 acute myocardial infarction 59 acute coronary syndromes 59 loop diuretics 59 Diastolic dysfunction 59 reach statistical significance 59 hypertension 59 invasive aspergillosis 59 artery stenosis 59 nocturia 59 Combination therapy 59 coronary revascularization 59 NATRECOR R 59 glomerular filtration 59 severe exacerbations 59 beta adrenergic receptor 59 DMARD 59 superficial bladder cancer 59 upper gastrointestinal bleeding 59 Atacand ® 59 inotropic 59 ADHF 59 irbesartan 59 deep venous thromboses 59 functional mitral regurgitation 59 postoperative pulmonary 59 angina 59 induce orthostatic hypotension 59 angiotensin converting enzyme ACE 59 flecainide 59 proteinuria 59 Chronic Heart Failure 59 ximelagatran 59 bypass grafting 59 paroxysmal atrial fibrillation 59 MACCE 59 acutely decompensated 59 UA NSTEMI 59 NYHA Class III 59 oral antidiabetic medication 59 carotid stenosis 59 rt PA 59 CABG coronary artery 59 OPCAB 59 pyridostigmine 59 macrovascular 59 overt nephropathy 59 olmesartan 59 varices 59 lipid lowering drugs 59 lipid lowering therapies 59 allopurinol 59 Statin therapy 59 Atacand 59 Congestive heart failure 59 nondiabetics 59 LVSD 59 achalasia 59 drugs hydralazine 59 nicardipine 59 acute coronary syndrome 59 #mmHg [001] 59 prostate TURP 59 ACTEMRA TM 59 primidone 59 antiplatelet drugs 59 juvenile idiopathic arthritis JIA 59 endometrial hyperplasia 59 elevated triglycerides 59 atrial fibrillation AF 59 microalbuminuria 59 hepatorenal syndrome 59 Aortic stenosis 59 candesartan cilexetil 59 clazosentan 59 Doxil ® 59 AV fistulas 59 troponin T 59 mitral stenosis 59 ACE inhibitor 59 attain statistical significance 59 dexrazoxane 58 proliferative diabetic retinopathy 58 VA# [002] 58 overt hypothyroidism 58 atherothrombotic events 58 glomerular filtration rate 58 severe mitral regurgitation 58 leukemia AML 58 antithrombotic agents 58 evaluating CK # 58 nasal obstruction 58 autonomic dysfunction 58 recombinant tissue plasminogen 58 intravenous diuretics 58 undergoing CABG 58 acute decompensation 58 BYSTOLIC 58 eosinophilic asthma 58 heparin induced thrombocytopenia 58 thromboembolism 58 perioperatively 58 clomipramine 58 chronic pancreatitis 58 nesiritide 58 heart arrhythmias 58 OAB symptoms 58 selective A1 adenosine 58 Starlix 58 HbA1c levels 58 anastomotic leak 58 antidiabetic drugs 58 Hypotension 58 coronary intervention 58 lipid lowering medications 58 6R BH4 58 CIMZIA TM certolizumab pegol 58 extrapyramidal symptoms 58 EDARBI 58 oral antidiabetic drugs 58 atherosclerotic lesions 58 elevated triglyceride levels 58 lipid lowering agents 58 silent ischemia 58 onset diabetes mellitus 58 intensive statin therapy 58 pentoxifylline 58 serum phosphate levels 58 bi ventricular pacing 58 Carotid Revascularization Endarterectomy vs. 58 ß blockers 58 antiplatelet medications 58 variceal bleeding 58 COREG 58 pulmonary arterial 58 noncardiac surgery 58 thromboembolic 58 familial hypercholesterolemia 58 functional dyspepsia 58 sorafenib Nexavar 58 Prehypertension 58 nonfasting triglycerides 58 post thrombotic syndrome 58 ischemic stroke 58 unruptured aneurysms 58 postoperative delirium 58 diabetic gastroparesis 58 ivabradine 58 recurrent ischemia 58 GRNCM1 58 mildly symptomatic 58 coronary blockages 58 rFVIIa 58 lipid abnormalities 58 mitral valve regurgitation 58 vasodilators 58 posttransplant 58 diabetes mellitus 58 antireflux surgery 58 impaired fasting glucose 58 salmeterol fluticasone 58 unstable angina pectoris 58 albuminuria 58 embolic stroke 58 reinfarction 58 corticosteroid therapy 58 severe renal insufficiency 58 angiotensin receptor blocker ARB 58 INTEGRILIN R 58 recurrent glioblastoma multiforme 58 angiotensin converting enzyme 58 T2DM 58 Thiazolidinediones 58 cerebral vasospasm 58 streptokinase 58 inotropes 58 recurrent VTE 58 infliximab Remicade 58 carotid artery blockage 58 moderate renal impairment 58 vWD 58 Eisenmenger syndrome 58 arrhythmias 58 cardiac conduction 58 acute aortic dissection 58 unstable angina UA 58 peripheral arterial disease 58 anticlotting drugs 58 airflow obstruction 58 cardiac hypertrophy 58 antihypertensive drugs 57 non valvular atrial 57 nephrotoxicity 57 elevated CRP 57 glitazones 57 systemic corticosteroid 57 torsade de pointes 57 Zileuton 57 nonresponders 57 liver histology 57 chronic myocardial ischemia 57 angiotensin II receptor blockers 57 AGILECT R 57 elevated IOP 57 pulmonary hypertension 57 NNT = 57 thiazide diuretics 57 carvedilol 57 basal cell nevus syndrome 57 PsA 57 MYDICAR 57 primary hypercholesterolemia 57 gastro oesophageal reflux 57 Adjunctive 57 aspartate aminotransferase AST 57 syncope 57 Nocturia 57 asystole 57 OADs 57 mild vasodilator 57 vessel occlusion 57 ketorolac 57 dilated cardiomyopathy DCM 57 coronary stenosis 57 ischemic mitral regurgitation 57 CYP #A# 57 bradycardia 57 purpura ITP 57 anticholinergics 57 rosuvastatin #mg 57 coronary calcification 57 Bucindolol 57 hypercholesterolaemia 57 nonvertebral fracture 57 ALLHAT 57 antiarrhythmic 57 oral corticosteroid 57 nonadherence 57 quetiapine Seroquel 57 metastatic malignant 57 Pulmonary hypertension 57 acarbose 57 angiotensin receptor blockers ARBs 57 ACE Inhibitors 57 Balloon angioplasty 57 AFib 57 urinary symptoms 57 cardiac insufficiency 57 Hypertrophy 57 progressive dyspnea 57 calcineurin inhibitors 57 hyperglycaemia 57 gastro oesophageal reflux disease 57 PICSO ® 57 metastatic lung cancer 57 beta blocker 57 androgen deficiency 57 stratifying patients 57 ruboxistaurin 57 rosuvastatin Crestor 57 renal toxicity 57 infarctions 57 Diastolic 57 Myelodysplastic Syndrome MDS 57 reperfusion therapy 57 Erythropoietic therapies may 57 AA Amyloidosis 57 ventricular fibrillation VF 57 refractory angina 57 uncontrolled hypertension 57 HCV RESPOND 2 57 ACEIs 57 leiomyomas 57 HMG CoA reductase inhibitors 57 VTE prophylaxis 57 infective endocarditis 57 mild renal insufficiency 57 mitral insufficiency 57 inotropic agents 57 Mipomersen 57 rhythm disturbances 57 tirofiban 57 ascites 57 aspirin clopidogrel 57 PAOD 57 myocardial fibrosis 57 cinacalcet 57 secondary hyperparathyroidism 57 fluid overload 57 unstable angina 57 losartan 57 pacemaker implantation 57 sotalol 57 nonvertebral fractures 57 Ranolazine 57 AVANDIA 57 hypercalcemia 57 retransplantation 57 serum phosphate 57 Inspra 57 metastatic malignant melanoma 57 atherosclerotic renal artery stenosis 57 glycoprotein IIb IIIa inhibitors 57 certolizumab 57 peptide BNP 57 esophagitis 57 H pylori 57 pulmonary artery catheterization 57 ACE inhibitor ramipril 57 renal allograft 57 xanthine oxidase inhibitor 57 undergoing coronary artery 57 diabetes mellitus T2DM 57 thromboembolic disease 57 proliferative retinopathy 57 thrombolytic agents 57 basiliximab 57 mL/min/#.# m 2 57 underwent angiography 57 terlipressin 57 osteoporotic vertebral compression fractures 57 TMP SMX 57 hypoxemia 57 anti TNF 57 mitral regurgitation 57 ibandronate 57 nephropathy 57 antiplatelet agents 57 contrast induced nephropathy 57 urinary retention 57 graft occlusion 57 Hypertensive 57 angioplasty stenting 57 periprocedural 57 nonischemic cardiomyopathy 57 hyperparathyroidism 57 hyperlipidaemia 57 cardiovascular morbidity 57 SHPT 57 antiarrhythmic drugs 57 TNF inhibitor 57 prehypertension 57 hepatocellular 57 systolic function 56 ZOLINZA 56 diastolic blood pressures 56 repeat revascularization 56 β blocker 56 pulmonary hypertension PH 56 acute humoral rejection 56 VAPRISOL 56 Non Alcoholic Fatty 56 aliskiren amlodipine 56 sustained ventricular tachycardia 56 LVADs 56 amiodarone 56 diabetic nephropathy 56 Rivaroxaban 56 Angiotensin receptor blockers 56 cardiovascular hospitalizations 56 dyssynchrony 56 TAXUS Express Stent 56 isosorbide dinitrate 56 cardiovascular mortality 56 acute STEMI 56 Oral corticosteroids 56 pulmonary arterial hypertension 56 CIPN 56 Mitral regurgitation 56 homozygous familial hypercholesterolemia 56 NPH insulin 56 claudication 56 cerebral infarction 56 cerebrovascular events 56 nasal polyps 56 pyelonephritis 56 kidney dysfunction 56 subclinical cardiovascular disease 56 stenosis 56 atherogenic dyslipidemia 56 cilostazol 56 pulmonary dysfunction 56 verapamil 56 narrow QRS 56 Anticoagulants 56 Hb A1C 56 intracerebral haemorrhage 56 Carvedilol 56 hypotensive 56 PLX STROKE targeting 56 nonpharmacologic 56 atrioventricular block 56 serum calcium levels 56 azacitidine 56 antiplatelet therapies 56 thiazides 56 vertebral fracture 56 serum phosphorous 56 BENICAR 56 CYPHER Stent 56 anticholinergic medications 56 DAPT 56 hypokalemia 56 defibrillator CRT D 56 severe aortic stenosis 56 antihypertensives 56 cardiac tamponade 56 lacunar 56 DFMO 56 ventricular dysfunction 56 myocardial infarction MI 56 gout flares 56 tissue plasminogen activator tPA 56 airflow limitation 56 intravenous bisphosphonates 56 aortic valves 56 beta blockers 56 calcium channel 56 cryptogenic stroke 56 lumbar disk herniation 56 arterial stiffening 56 sunitinib 56 carotid artery stenosis 56 diastolic pressures 56 sinus node dysfunction 56 Hyperlipidemia 56 spironolactone 56 aspirin heparin 56 bronchial hyperresponsiveness 56 EXJADE 56 thyroid hormone replacement 56 aminotransferases 56 ischemic complications 56 artery calcification 56 ertapenem 56 T1DM 56 pressor response 56 chronic eosinophilic leukemia 56 recurrent venous thromboembolism 56 drotrecogin alfa activated 56 diastolic pressure 56 receiving VELCADE 56 INVEGA ® 56 Avandia Actos 56 valvular heart disease 56 gastroparesis 56 oral anticoagulants 56 graft dysfunction 56 Non Alcoholic Steatohepatitis 56 efalizumab 56 TNF antagonist 56 retinal vein occlusion 56 hepatic encephalopathy 56 oral anticoagulation 56 NAFLD 56 advanced adenomas 56 blocked carotid arteries 56 statins 56 corticosteroid dose 56 renal artery stenosis 56 treat benign prostatic 56 carotid intima media 56 valve implantation 56 fibrinolytic therapy 56 NYHA 56 ANCA associated 56 baclofen 56 metastatic RCC 56 ACC AHA 56 valsartan 56 hypoperfusion 56 oesophageal adenocarcinoma 56 carcinoid tumors 56 coronary vessels 56 hemorrhagic complications 56 elective PCI 56 fibromyalgia syndrome 56 noninfectious uveitis 56 serum triglycerides 56 Thal Dex 56 ACE inhibitor lisinopril 56 RF ablation 56 mechanically ventilated patients 56 DULERA 56 thromboembolic events 56 APTIVUS r 56 antimuscarinic 56 BPH LUTS 56 pernicious anemia 56 coronary disease 56 Proteinuria 56 intracranial atherosclerosis 56 myocardial perfusion imaging 56 invasive candidiasis 56 MULTAQ 56 surgical revascularization 56 chlorthalidone 56 OSAHS 56 hemodynamically unstable 56 postoperative morbidity 56 infarct size 56 natriuretic peptides 56 thromboembolic complications 56 imatinib therapy 56 nitroprusside 56 stress cardiomyopathy 56 obstructive sleep apnea 56 perindopril 56 patients undergoing CABG 56 allogeneic HSCT 56 Beta blockers 56 chronic angina 56 thrombocytopenic 56 prolonged QT interval 56 metabolic acidosis 56 myocyte 56 thyrotoxicosis 56 restenosis reblockage 56 metastatic renal cell carcinoma 56 Amiodarone 56 arterial calcification 56 cardiac troponin 56 surgically induced 56 Acute renal failure 56 Venous thromboembolism 56 Cypher Stent 56 edifoligide 56 calcineurin inhibitor 56 cytopenias 56 AV grafts 56 systemic corticosteroids 56 hemorrhagic strokes 56 GH deficiency 56 CrCl 56 PSVT 56 dyslipidemia 56 Tiotropium 56 nonoperative 56 Darapladib 56 invasive coronary angiography 56 Perforomist Inhalation Solution 56 nonfasting triglyceride levels 56 blocked coronary arteries 56 thrombotic complications 56 echocardiographic parameters 56 esomeprazole Nexium 56 Ischemia 56 urge incontinence 56 binary restenosis 56 CMV disease 56 uncoated stents 56 vasopressor 56 adenomatous 56 adrenal insufficiency 56 invasive fungal infection 56 intravenous cyclophosphamide 56 Orthostatic hypotension 55 CUPID trial 55 bacteriuria 55 prescribe statins 55 overactive bladder OAB 55 lichen planus 55 gouty arthritis 55 pulmonary capillary wedge 55 hypertension congestive heart 55 INCB# [003] 55 arteriography 55 catheter ablation 55 Hydroxyurea 55 Helicobacter pylori infection 55 metastatic carcinoid tumors 55 hypertensive patients 55 platelet inhibition 55 osteoporotic 55 perioperative morbidity 55 smoldering multiple myeloma 55 pioglitazone 55 idarubicin 55 heavy menstrual bleeding 55 gastrointestinal reflux 55 biologic therapy 55 carotid atherosclerosis 55 CRVO 55 bypass grafts 55 interferon ribavirin 55 enalapril 55 Telmisartan 55 Afib 55 disordered breathing 55 QTc prolongation 55 euthymic patients 55 Critical Limb Ischemia CLI 55 dosing frequency 55 electrolyte abnormalities 55 CPVT 55 delayed gastric emptying 55 zolmitriptan 55 chronic renal insufficiency 55 carotid IMT 55 hyperacute 55 CYP#C# [001] 55 polyp recurrence 55 abnormal lipids 55 sinus bradycardia 55 Inhaled nitric oxide 55 dysuria 55 teriparatide 55 Dabigatran 55 minimally symptomatic 55 cardiomyopathies 55 limb ischemia 55 Alzheimer Disease AD 55 liver metastasis 55 antithrombotic 55 CMV infection 55 anakinra 55 abacavir lamivudine 55 paclitaxel eluting stents 55 aspirin beta blockers 55 serum urate levels 55 Inhaled insulin 55 dissolving blood clots 55 urinary tract symptoms LUTS 55 Microalbuminuria 55 interstitial pneumonia 55 silent myocardial ischemia 55 venlafaxine Effexor 55 microvascular complications 55 MGUS 55 recurrent sinusitis 55 intracranial stenosis 55 hypovolemic 55 TACE 55 macrovascular events 55 Fonarow 55 mm Hg systolic 55 HbA1C 55 antihypertensive agents 55 cTnT 55 COPD 55 ReoPro 55 metformin sulfonylurea 55 cardiovascular disease hypertension 55 HoFH 55 aliskiren 55 revascularisation 55 cryptogenic 55 oral antidiabetic agents 55 short bowel syndrome 55 intact parathyroid hormone 55 cirrhotic patients 55 pancreatic insufficiency 55 pulmonary vasculature 55 valvular heart 55 dronedarone 55 transvenous 55 symptomatic intracranial 55 Mitral valve 55 TMS Therapy 55 fecal incontinence 55 Ivabradine 55 ADPKD 55 thrombolytic agent 55 Cardiac Failure 55 ventricular arrhythmias 55 amenorrhoea 55 estimated glomerular filtration 55 thiazide 55 ACTOplus met 55 hemodynamic instability 55 ischemic lesions 55 idraparinux 55 clopidogrel Plavix 55 neovascular AMD 55 lowering systolic blood 55 GRK2 55 arterial hypertension 55 revascularizations 55 eptifibatide 55 Lung transplantation 55 CETP inhibition 55 perioperative mortality 55 typical antipsychotics 55 primary hyperparathyroidism 55 malabsorptive 55 left ventricular LV 55 exhaled nitric oxide 55 cardioembolic stroke 55 Adjuvant chemotherapy 55 Pioglitazone 55 statin monotherapy 55 VIIBRYD 55 Nilotinib 55 Aliskiren 55 autoantibody positive 55 somatostatin analogs 55 phosphate binders 55 carotid artery intima media 55 carotid plaque 55 alagebrium 55 metformin sulphonylurea 55 lipoprotein levels 55 DETROL LA 55 desmopressin 55 symptomatic VTE 55 #.#/#.# mmHg [001] 55 TEVAR 55 reflux esophagitis 55 hyperalgesia 55 cystatin C 55 teriflunomide 55 TNF alpha inhibitor 55 Catheter ablation 55 postsurgical 55 Rheos System 55 arterial thickening 55 Bairey Merz 55 Benign prostatic hyperplasia BPH 55 MPS IVA 55 Gastroparesis 55 cardiovascular hospitalization 55 oral anticoagulant therapy 55 nonrandomized 55 perfusion defects 55 inhaled corticosteroids ICS 55 GISTs 55 cranial irradiation 55 thoracoscopic lobectomy 55 myocardial reperfusion 55 Decompensated Heart Failure 55 bioprosthetic valve 55 thrombus aspiration 55 metaplasia 55 VaD 55 bacterial prostatitis 55 open angle glaucoma 55 HCV SPRINT 55 Natalizumab 55 RAS blockers 55 prophylactic therapy 55 XZK 55 prostate cancer CaP 55 serum urate 55 CP CPPS 55 achieve sustained virologic 55 potassium sparing diuretics 55 mitochondrial toxicity 55 rheumatoid arthritis osteoarthritis ankylosing 55 anthracycline therapy 55 acute coronary syndromes ACS 55 HeFH 55 HBeAg negative 55 alfuzosin 55 atrioventricular valve 55 hydroxychloroquine 55 vascular inflammation 55 Benign Prostatic Hyperplasia BPH 55 beta blocker atenolol 55 deep vein thromboses 55 opioid induced 55 hypoparathyroidism 55 renal insufficiency 55 relapsed MM 55 lispro 55 bosentan 55 abnormal heartbeats 55 TEAEs 55 tricuspid regurgitation 55 elevated LDL cholesterol 55 serum sodium 55 fibrosis scarring 55 pouchitis 55 postoperative complication 55 Bosentan 55 urate levels 55 oral hypoglycemic agents 55 symptomatic aortic stenosis 55 clot busting therapy 55 tachyarrhythmias 55 amisulpride 55 hyperphenylalaninemia HPA due 55 chorioamnionitis 55 nonfatal heart 55 lung metastasis 55 colectomy 55 Haptoglobin 55 Non inferiority 55 NOMID 55 Atrial fibrillation AF 55 severe hypoglycaemia 55 acute GVHD 55 treprostinil 55 biventricular 55 pulmonary artery banding 55 C1 INH deficiency 55 pulmonary arterial hypertension PAH 55 fallopian tube cancers 55 hypertension diabetes mellitus 55 acne vulgaris 55 clevidipine 55 stented 55 echocardiographic 55 intracerebral hemorrhage 55 giant cell arteritis 55 calculi 55 elevated serum creatinine 55 antiplatelet agent 55 Desferal 55 leukocyte count 55 STRIDE PD 55 Potiga 55 calcium antagonists 55 ST elevation myocardial 55 clinically detectable 55 Crohn disease CD 55 nonalcoholic steatohepatitis 55 systemic hypotension 55 apelin 55 deferoxamine 55 patients undergoing percutaneous 55 reslizumab 55 Mitral Regurgitation 55 varicoceles 55 tenecteplase 55 VADT 55 angiotensin converting enzyme inhibitor 55 congestive cardiac 55 immunosuppressive agents 55 warfarin therapy 55 asymptomatic PAD 55 fraction LVEF 55 postoperative bleeding 55 arteriovenous fistula 55 untreated celiac disease 55 failure NYHA 55 hyperphosphatemia 55 urolithiasis 55 osteopenic 55 DU #b 55 relapsing MS 55 basal cell cancers 55 mechanical dyssynchrony 55 SGRQ 55 Chronic Myeloid Leukemia 55 Vitamin B# deficiency 55 symptomatic paroxysmal AF 55 preoperative chemotherapy 55 statin therapy 55 NYHA Class 55 H2 blockers 55 dutasteride 55 normotensive 55 cerebral ischemia 55 PREZISTA r 55 celecoxib 55 vWF 55 type2 diabetes 55 Androgen deprivation therapy 55 docetaxel Taxotere ® 55 urethral stricture 55 non cirrhotic portal 55 onset seizures